Clinical Evaluation on Fufang Biejia Ruangan Tablets and Mangan Jieyu Capsules for Treating Cirrhosis after Hepatitis
|更新时间:2024-09-23
|
Clinical Evaluation on Fufang Biejia Ruangan Tablets and Mangan Jieyu Capsules for Treating Cirrhosis after Hepatitis
Chinese Journal of Experimental Traditional Medical FormulaeVol. 19, Issue 5, Pages: 327-329(2013)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2013
稿件说明:
移动端阅览
WU Jun-wei. Clinical Evaluation on Fufang Biejia Ruangan Tablets and Mangan Jieyu Capsules for Treating Cirrhosis after Hepatitis[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(5): 327-329.
DOI:
WU Jun-wei. Clinical Evaluation on Fufang Biejia Ruangan Tablets and Mangan Jieyu Capsules for Treating Cirrhosis after Hepatitis[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(5): 327-329.DOI:
Clinical Evaluation on Fufang Biejia Ruangan Tablets and Mangan Jieyu Capsules for Treating Cirrhosis after Hepatitis
Objective:To study the clinical curative effect and the influence of the life quality of Fufang Biejia Ruangan tablets (FBRT) and Mangan Jieyu capsules (MJC) for treating cirrhosis after hepatitis (compensatory period). Method: Seventy-four cases of cirrhosis after hepatitis were randomly divided into the treatment group (n=35) and the control group (n=39). Two groups were given conventional liver-protecting drugs and antiviral treatment
meanwhile the treatment group was treated by FBRT 4 tablets tid
MJC 4 capsules tid. The course of treatment was 24 weeks. Clinical symptoms
life quality
hyaluronic acid (HA)
laminin (LN)
type Ⅲ procollagen (PC Ⅲ)
type IV collagen (IV-C) were observed and determined. Result: After treatment (12
24 weeks) clinical symptoms scores in the treatment group were lower than those in control group (P<0.01). HA
LN
PC Ⅲ and IV-C in the treatment group were lower than those of the control group (P<0.05
P<0.01). The total scores in physiological
psychological and social aspects in treatment group were significantly higher than those in the control group (P<0.05
P<0.01). The effective rate was 87.18% in the treatment group
and 65.71% in the controls (P<0.05). Conclusion: For treating cirrhosis after hepatitis (compensatory period)
FBRT and MJC can obviously relieve clinical symptoms
Clinical Evaluation on Fufang Biejia Ruangan Tablets and Mangan Jieyu Capsules for Treating Cirrhosis after Hepatitis
Clinical Efficacy and Bone Turnover Markers of Buzhong Yiqitang in Treatment of Senile Osteoporotic Vertebral Compression Fracture After Operation Based on ''Spleen Governing Muscle''
Effect of Mashao Pingchuan Decoction on Traditional Chinese Medicine Symptoms and Quality of Life in Patients with Cold Asthma of Bronchial Asthma
Research Progress on Mechanism of Yiguanjian Intervention in Liver Cirrhosis
Effect of Jinshuibao Capsule and Domiciliary Oxygen Therapy on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease at Stationary Phase
Related Author
WU Jun-wei
Bocheng LIANG
Yuzhou LU
Jingwei XU
Yadong WU
Zhenguang GUO
Wenjie DENG
Xiaoyan QI
Related Institution
The Fourth People’s Hospital of Chongqing City
Rizhao Hospital of Traditional Chinese Medicine
People's Hospital of Rizhao
The Second Affiliated Hospital of Zhejiang Chinese Medical University
Graduate School,Anhui University of Chinese Medicine